Using genetically modified mice which are unable to release superoxide anions and superoxide-derived oxidants from NAD(P)H oxidases (NOX), it has been found that PM2.5 increases obesity and insulin resistance in vivo by NAD(P)H oxidase-derived superoxide anions [62]. The gene discussed is FMO5; the disease is obesity disorder.